Early treatment of the first MOGAD acute attack may prevent future relapses and reduce long-term humoral autoimmunity in patients.

A Maine-based company that uses a lobster byproduct for its lotions and treatment has a brand-new product out. In this ...

Accumulation of extracellular matrix (ECM) in liver fibrosis is associated with changes in protein abundance and composition depending upon etiology of the underlying liver disease. Current efforts to ...

The vaccine comprises an mRNA sequence that encodes the RSV F glycoprotein, which is essential for the virus' ability to ...

Results also showcase the successful design of a proprietary prefusion glycoprotein B (gB) antigen with ability to neutralize the virus About 1 in 200 babies is born with congenital CMV infection and ...

Health Canada approves Moderna’s RSV vaccine, mRESVIA for adults aged 60 years and older: Cambridge, Massachusetts Monday, November 11, 2024, 12:00 Hrs [IST] Moderna, Inc., a le ...

RESVIA is Moderna's second approved product in Canada, the first mRNA vaccine against RSV, and the only one in single-dose pre-filled syringesCanada is the fourth jurisdiction to approve mRESVIA ...

New preclinical data demonstrates that CMV antigens identified with Evaxion's AI-Immunology platform trigger targeted immune responses Results also showcase the successful design of a proprietary pref ...